KALY CEO Frederick Ferri indicated that the interest stems from industry investors recognizing that KALY’s technology is undervalued.
DALLAS, Oct. 24, 2019 (GLOBE NEWSWIRE) — via OTC PR WIRE — Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today confirmed a recent conditional acquisition proposal from an investor interested in the acquisition of KALY’s Cannabis Extract Biopharmaceutical Technology.
KALY CEO Frederick Ferri commented yesterday on the acquisition interest in KALY’s Cannabis Extract Biopharmaceutical Technology indicating that the interest stems from industry investors recognizing that KALY’s technology is undervalued. KALY plans to issue an update next Wednesday, October 30th, 2019 regarding the acquisition interest.
Thank you for your sharing. I am worried that I lack creative ideas. It is your article that makes me full of hope. Thank you. But, I have a question, can you help me? https://accounts.binance.com/en-IN/register?ref=UM6SMJM3